Skip to content
OpenCapital
Get started

LivaNova LIVN Cash Provided by (Used in) Operating Activity, Including Discontinued Operation

Cash Provided by (Used in) Operating Activity, Including Discontinued Operation at other companies

Haemonetics logo
HaemoneticsHAE
$70.94M-39.1%
Merit Medical Systems logo
Merit Medical SystemsMMSI
$40.68M+0.3%
Baxter International logo
Baxter InternationalBAX
$213M+210%
Medtronic logo
MedtronicMDT
——
ResMed logo
ResMedRMD
——
Globus Medical logo
Globus MedicalGMED
——

Other financials

Income statement

See full
Revenue$362.3M+14.3%
Gross profit$243.7M+12.7%
Operating income$41.5M-14.7%
Net income$22.3M+107%
EPS (diluted)$0.40+107%

Balance sheet

See full
Cash & equivalents$539.7M-26.9%
Total debt$340.9M-49.7%
Total equity$1.2B+17.1%
Total assets$2.5B-1.7%

Cash flow

See full
Operating cash flow$15.2M-36.5%
CapEx$14.3M+32.4%
Free cash flow$926.0K-93.0%

Valuation

See full
Market cap$4.32B+62.8%

Profitability

See full
Gross margin67.5%-0.5pp
Operating margin13.4%+0.8pp
Net margin-16.1%-18.0pp
FCF margin11.2%-0.2pp

Returns & leverage

See full
Return on equity-17.6%-19.5pp
Debt / equity0.3×-0.4×
Current ratio1.3×-0.2×

Where this comes from

Reported directly by LivaNova in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.

The official record: LivaNova’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about LivaNova's cash provided by (used in) operating activity, including discontinued operation.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is LivaNova's cash provided by (used in) operating activity, including discontinued operation?
LivaNova (LIVN) reported cash provided by (used in) operating activity, including discontinued operation of $15.22M in Q1 2026.
How has LivaNova's cash provided by (used in) operating activity, including discontinued operation changed year-over-year?
LivaNova's cash provided by (used in) operating activity, including discontinued operation decreased by 36.5% year-over-year, from $23.97M to $15.22M.
What is the long-term trend for LivaNova's cash provided by (used in) operating activity, including discontinued operation?
Over 2 years (2021 to 2025), LivaNova's cash provided by (used in) operating activity, including discontinued operation has grown at a 57.5% compound annual growth rate (CAGR), from $102.54M to $254.34M.
What does cash provided by (used in) operating activity, including discontinued operation mean?
Measures the cash generated from the company's core business operations, excluding financing and investing activities. It reflects the ability of the company to convert revenue into actual cash flow after accounting for changes in working capital.